{"DataElement":{"publicId":"3206372","version":"1","preferredName":"Cervix Uteri Malignant Neoplasm Characteristic Type","preferredDefinition":"the type of distinguishing qualities or prominent aspect of cervical cancer, a tumor composed of atypical neoplastic cells originating from the lower, narrow end of the uterus that forms a canal between the uterus and vagina.","longName":"3206365v1.0:3206366v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3206365","version":"1","preferredName":"Cervix Uteri Malignant Neoplasm Characteristic","preferredDefinition":"information related to the distinguishing qualities or prominent aspect of cervical cancer, a tumor composed of atypical neoplastic cells originating from the lower, narrow end of the uterus that forms a canal between the uterus and vagina.","longName":"2888997v1.0:2548312v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2888997","version":"1","preferredName":"Cervix Uteri Malignant Neoplasm","preferredDefinition":"(SER-viks) The lower, narrow end of the uterus that forms a canal between the uterus and vagina.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C12311:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervix Uteri","conceptCode":"C12311","definition":"The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AC9D1EC-FD49-7E4D-E040-BB89AD433973","latestVersionIndicator":"Yes","beginDate":"2009-05-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-26","modifiedBy":"ONEDATA","dateModified":"2009-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2548312","version":"1","preferredName":"Characteristics","preferredDefinition":"Characteristics; distinguishing qualities of a person, object, or substance.","longName":"C25447","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Characteristic","conceptCode":"C25447","definition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2390D6A7-4632-702F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-12-01","modifiedBy":"ONEDATA","dateModified":"2006-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F150CA7-4782-AB37-E040-BB89AD434F31","latestVersionIndicator":"Yes","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3206366","version":"1","preferredName":"Cervix Uteri Malignant Neoplasm Type","preferredDefinition":"the type of Cervix Uteri Malignant Neoplasm","longName":"3206366v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Negative capillary-lymphatic space involvement, deep third penetration, Clinical tumor >= 4 cm","valueDescription":"Negative capillary-lymphatic space involvement, deep third penetration, Clinical tumor >= 4 cm","ValueMeaning":{"publicId":"3206367","version":"1","preferredName":"Negative capillary-lymphatic space involvement, deep third penetration, Clinical tumor >= 4 cm","longName":"3206367","preferredDefinition":"Negative capillary-lymphatic space involvement, deep third penetration, Clinical tumor >= 4 cm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F150CA7-47A8-AB37-E040-BB89AD434F31","latestVersionIndicator":"Yes","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F150CA7-47C1-AB37-E040-BB89AD434F31","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"ONEDATA","dateModified":"2011-03-22","deletedIndicator":"No"},{"value":"Negative capillary-lymphatic space involvement, Middle third penetration, Clinical tumor >= 4 cm","valueDescription":"Negative capillary-lymphatic space involvement, Middle third penetration, Clinical tumor >= 4 cm","ValueMeaning":{"publicId":"3206368","version":"1","preferredName":"Negative capillary-lymphatic space involvement, Middle third penetration, Clinical tumor >= 4 cm","longName":"3206368","preferredDefinition":"Negative capillary-lymphatic space involvement, Middle third penetration, Clinical tumor >= 4 cm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F150CA7-47CB-AB37-E040-BB89AD434F31","latestVersionIndicator":"Yes","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F150CA7-47E4-AB37-E040-BB89AD434F31","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"ONEDATA","dateModified":"2011-03-22","deletedIndicator":"No"},{"value":"Positive capillary-lymphovascular space involvement, Superficial third penetration, clinical tumor >= 5 cm","valueDescription":"Positive capillary-lymphovascular space involvement, Superficial third penetration, clinical tumor >= 5 cm","ValueMeaning":{"publicId":"3206369","version":"1","preferredName":"Positive capillary-lymphovascular space involvement, Superficial third penetration, clinical tumor >= 5 cm","longName":"3206369","preferredDefinition":"Positive capillary-lymphovascular space involvement, Superficial third penetration, clinical tumor >= 5 cm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F150CA7-47EE-AB37-E040-BB89AD434F31","latestVersionIndicator":"Yes","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F150CA7-4807-AB37-E040-BB89AD434F31","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"ONEDATA","dateModified":"2011-03-22","deletedIndicator":"No"},{"value":"Positive capillary-lymphovascular space involvement, Middle third penetration, clinical tumor >= 2 cm","valueDescription":"Positive capillary-lymphovascular space involvement, Middle third penetration, clinical tumor >= 2 cm","ValueMeaning":{"publicId":"3206370","version":"1","preferredName":"Positive capillary-lymphovascular space involvement, Middle third penetration, clinical tumor >= 2 cm","longName":"3206370","preferredDefinition":"Positive capillary-lymphovascular space involvement, Middle third penetration, clinical tumor >= 2 cm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F150CA7-4811-AB37-E040-BB89AD434F31","latestVersionIndicator":"Yes","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F150CA7-482A-AB37-E040-BB89AD434F31","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"ONEDATA","dateModified":"2011-03-22","deletedIndicator":"No"},{"value":"Positive capillary-lymphovascular space involvement and deep third penetration","valueDescription":"Positive capillary-lymphovascular space involvement and deep third penetration","ValueMeaning":{"publicId":"3206371","version":"1","preferredName":"Positive capillary-lymphovascular space involvement and deep third penetration","longName":"3206371","preferredDefinition":"Positive capillary-lymphovascular space involvement and deep third penetration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F150CA7-4834-AB37-E040-BB89AD434F31","latestVersionIndicator":"Yes","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F150CA7-484D-AB37-E040-BB89AD434F31","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"ONEDATA","dateModified":"2011-03-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F150CA7-4793-AB37-E040-BB89AD434F31","latestVersionIndicator":"Yes","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"CAMPBELB","dateModified":"2011-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104885","version":"1","longName":"GOG-0263","context":"NRG"}]}],"AlternateNames":[{"name":"3206365v1.0:3206366v1.0","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Please select the option whic","type":"Preferred Question Text","description":"Please select the option which best describes the patient's disease characteristics:","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F150CA7-4857-AB37-E040-BB89AD434F31","latestVersionIndicator":"Yes","beginDate":"2011-03-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-22","modifiedBy":"FORMBUILDER","dateModified":"2014-09-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}